Skip to main content
logo
Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.770
-0.110 (-2.25%)
At close: May 13, 2026, 4:00 PM EDT
4.740
-0.030 (-0.63%)
Pre-market: May 14, 2026, 4:00 AM EDT

Intensity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
132627117--
Market Cap Growth
38.66%-2.73%-77.35%---
Enterprise Value
2.514.0524.14102.8500
Last Close Price
4.7710.2644.00214.25--
PE Ratio
--1.20-1.50-6.21--
PB Ratio
1.212.189.128.93--
P/TBV Ratio
0.881.178.395.61--
P/FCF Ratio
--2.80-1.75-16.31--
P/OCF Ratio
--2.80-1.75-16.31--
EV/EBITDA Ratio
--1.18-1.46-12.59--
EV/EBIT Ratio
--1.17-1.46-12.36--
EV/FCF Ratio
--1.52-1.59-14.27--
Debt / Equity Ratio
0.010.010.040.0100.11
Debt / EBITDA Ratio
-0.01-0.01-0.01-0.02-0.02-0.04
Debt / FCF Ratio
-0.01-0.01-0.01-0.02-0.03-0.05
Net Debt / Equity Ratio
-1.02-0.99-0.84-1.110.080.49
Net Debt / EBITDA Ratio
0.920.990.151.790.160.54
Net Debt / FCF Ratio
1.121.280.162.030.210.62
Quick Ratio
4.575.551.483.730.191.22
Current Ratio
4.865.921.923.910.211.27
Return on Equity (ROE)
-97.85%-156.90%-202.34%-261.36%400.94%-161.84%
Return on Assets (ROA)
-84.15%-126.79%-150.24%-87.33%-216.55%-104.31%
Return on Invested Capital (ROIC)
22432.30%-4509.23%3476.94%503.88%553.79%1351.85%
Return on Capital Employed (ROCE)
-100.93%-159.81%-202.70%-201.09%423.38%-155.61%
Earnings Yield
-84.61%-83.47%-66.45%-16.10%--
FCF Yield
--35.66%-57.18%-6.13%--
Buyback Yield / Dilution
-221.96%-143.83%-61.40%-152.67%0.00%-0.02%
Total Shareholder Return
-221.96%-143.83%-61.40%-152.67%0.00%-0.02%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q